O'PKA SARATONI DIAGNOSTIKASI VA STADIYALASHTIRISHDA EBUS-TBNA NING AFZALLIKLARI
Abstract
Annotatsiya / Аннотация / Abstract
Dolzarbligi: O'pka saraton kasalligi dunyo bo'yicha eng keng tarqalgan
onkologik kasalliklardan biri bo'lib, GLOBOCAN 2022 ma'lumotlariga ko'ra har yili
2,48 million yangi holat qayd etiladi va 1,82 million bemor hayotini yo'qotadi.
Kasallikni kech aniqlash belgilangan prognozni sezilarli darajada yomonlashtiradi.
Maqsad: O'pka saraton kasalligini diagnostika qilish va stadiyalashtirish
jarayonida EBUS-TBNA ning an'anaviy usullarga nisbatan afzalliklarini tizimli tahlil
qilish.
References
Список литературы
1. Zhou J, Xu Y, Liu J, et al. Global burden of lung cancer in 2022 and
projections to 2050: incidence and mortality estimates from GLOBOCAN.
Cancer Epidemiol. 2024;93:102693. doi:10.1016/j.canep.2024.102693
2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022:
GLOBOCAN estimates. CA Cancer J Clin. 2024;74(3):229–263.
doi:10.3322/caac.21834
3. Gildea TR, Murgu SD. The role of bronchoscopy in the diagnosis of
early lung cancer: a review. J Thorac Dis. 2016;8(Suppl 9):S629–S640.
PMC5179455
4. Yasufuku K, Chiyo M, Sekine Y, et al. Real-time endobronchial
ultrasound-guided transbronchial needle aspiration of mediastinal and hilar
lymph nodes. Chest. 2004;126(1):122–128. doi:10.1378/chest.126.1.122
5. Gasparini S. Bronchoscopic biopsy techniques in the diagnosis and
staging of lung cancer. Monaldi Arch Chest Dis. 1997;52(4):392–398. PMID
9380885
6. Tournoy KG, Keller SM, Annema JT. Mediastinal staging of lung
cancer: novel concepts. Lancet Oncol. 2012;13(5):e221–e229.
doi:10.1016/S1470-2045(11)70407-7
7. DiBardino DM, Yarmus LB, Semaan RW. Transthoracic needle biopsy
of the lung. J Thorac Dis. 2015;7(Suppl 4):S304–S316. PMC4703664
8. Olteanu M, Motas N, Andrei GM, et al. Balancing accuracy, safety, and
cost in mediastinal diagnostics: systematic review of EBUS and mediastinoscopy
in NSCLC (100 studies). PMC12346525. 2025
9. Badaoui A, De Wergifosse M, Rondelet B, et al. Improved accuracy and
sensitivity in diagnosis and staging of lung cancer with combined EBUS-EUS.
Cancers (Basel). 2024;16(4):728. doi:10.3390/cancers16040728
10. Olteanu M, Motas N, Cioboata R, et al. EBUS-TBNA for lung cancer:
regional analysis integrating molecular data (EXPoSURE). J Clin Med.
2025;14:6179. doi:10.3390/jcm14176179
11. Olteanu M, Motas N, Andrei GM, et al. Refining lung cancer diagnosis
with bronchoscopy and EBUS-TBNA. Medicina. 2025;61:1528. PMC12471518
12. Fernandez-Bussy S, Labarca G, Sanz-Santos J, et al. Robotic-assisted
bronchoscopy: narrative review. J Thorac Dis. 2024. doi:10.21037/jtd
13. Froudarakis ME, Zarogoulidis P, Porpodis K, et al. Robotic-assisted
bronchoscopy — advancing lung cancer management. Front Surg.
2025;12:1566902. PMC12172655
14. NLST Research Team. Reduced lung-cancer mortality with LDCT
screening. N Engl J Med. 2011;365:395–409. doi:10.1056/NEJMoa1102873
15. de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-
cancer mortality with volume CT screening (NELSON). N Engl J Med.
2020;382:503–513. doi:10.1056/NEJMoa1911793
16. van Klaveren RJ, Oudkerk M, Prokop M, et al. NELSON: screening
test performance and interval cancers. Lancet Oncol. 2014;15:1342–1350. PMID
25282284
